StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)

Close on Nov 17, 2026Market cap $399.15MP/E –Yield –

Eupraxia Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$28.55M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$28.55M–
FY2024Dec 31, 2024-$29.99M–
FY2023Dec 31, 2023-$20.75M–
FY2022Dec 31, 2022-$14.40M–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?